Products

Well prepared for the cold season: the EUROArray PneuVir provides clarity on viral respiratory infections

The start of autumn is currently very noticeable in the northern hemisphere: leaves are changing colour, temperatures are dropping and the days are getting shorter. And in line with this, the German Robert-Koch Institute reports a significantly increased activity for acute respiratory infection in Germany, which is higher than usual for this season. The most […]

Products

Revvity’s EUROIMMUN Launches Solution for Specific Typing of Alzheimer’s Disease Associated APOE Gene

Press release October 2nd 2024 APOE genotyping allows assessment of a patient’s risk for adverse effects from new anti-amyloid therapy for Alzheimer’s Revvity, Inc. (NYSE: RVTY), announced today the launch of the in-vitro diagnostic assay in European countries that accept the CE mark, which will enable accurate genotyping of the APOE gene. APOE genotyping is

Products

Increasing spread of infectious diseases due to climate change

Experts worldwide have identified climate change as the greatest health challenge of the 21st century. There is growing evidence that climatic changes also favour the emergence, recurrence and spread of infectious diseases. However, the full extent of this worrying development is still insufficiently investigated. In a study from 2022, researchers analysed the literature and found

Products

Reliable, fast and easy – IFA diagnostics in rheumatology

With passion for rheumatology! Indirect immunofluorescence assays (IFAs) such as for anti-nuclear antibody (ANA) testing are an important diagnostic tool in rheumatology. However, manual processing and evaluation of IFAs requires trained professionals and a lot of time. With innovative solutions and modern technologies, EUROIMMUN makes an important contribution to continuous development in immunofluorescence diagnostics and

Scroll to Top